A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer
Clinical trial NCT02321540 · COMPLETED
Trial details
- NCT number
- NCT02321540
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-31
- Primary completion
- 2021-09-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.